Stay updated on Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page reorganizes location information by adding a general 'Locations' section and listing states (California, Colorado, Massachusetts, Michigan). The 'HHS Vulnerability Disclosure' link is removed and the revision version updated from v3.3.2 to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-17T20:35:52.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
     Revision: v3.3.2 was added and v3.2.0 was removed, updating the page's revision history, with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-26T13:51:29.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page; all critical study information (title, eligibility criteria, endpoints, and locations) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T08:34:05.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The two screenshots show the same page with no added or removed sections affecting the study information. Any differences appear to be minor details like update timestamps.
    Difference
    0.5%
    Check dated 2025-10-28T05:14:04.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Upgraded the site to version v3.2.0 with a prominent operating-status notice for funding constraints, replacing the previous v3.1.0. Users are directed to official status sources for updates.
    Difference
    3%
    Check dated 2025-10-06T16:04:17.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T09:58:07.000Z thumbnail image

Stay in the know with updates to Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.